Other names: Nourianz®
Categories: Prescription Medication
Description:
Istradefylline (Nourianz®) is an adenosine A2A receptor antagonist used as an add-on therapy to levodopa/carbidopa in Parkinson’s disease. It helps reduce “off” episodes by modulating brain signaling pathways involved in motor control, offering a non-dopaminergic approach. Clinical studies show modest improvements in daily “on” time without troublesome dyskinesias. Common side effects include dyskinesia, hallucinations, dizziness, constipation, and insomnia. While not a first-line therapy, istradefylline provides an additional option for patients whose symptoms are not fully controlled with standard dopaminergic drugs.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment 'Istradefylline' against 'Parkinson's Disease'. The author has not provided any review or rating for this treatment. Therefore, the effectiveness of Istradefylline in treating Parkinson's Disease cannot be determined from the given data.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
